Temperature-controlled supply chain solutions firm Cryoport has partnered with cell and gene therapy specialist Minaris Regenerative Medicine to provide fully integrated logistics and manufacturing services for biotechnology and pharmaceutical companies.
Specifically, the partnership will focus on logistics and services for regenerative medicine products to support the advancement of cell and gene therapies, which are procedures that involve altering the genes inside a body’s cells to treat or stop disease.
A lot of gene therapies need to be stabilised by cryogenic preservation during storage and transportation. Speaking to gasworld earlier this year, Cryoport’s President and CEO described cryogenics as the medium that maintains the temperature profile of the cellular materials.
Read more: How Cryoport stays ahead in delivering cell and gene therapies
... to continue reading you must be subscribed
